Progression-free survival and overall survival after start of therapy for FCM or R-FCM. (A) Progression-free survival; (B) overall survival. The estimated median PFS is 16 months for R-FCM as compared with 10 months for FCM (P = .0381). The median OS is not reached for R-FCM as compared with 24 months (estimated) for FCM (P = .0030).